Ernest Bloom, MD
Dermatology · Alameda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 2
Offices
2 locations · Csi Medical Group · 104 clinicians in this group
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bloom’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G56359 · Current
Licensed to practise in California · since 1985 · expires 2027-06-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$213,790
Medicare paid this office $213,790 for 440 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of precancer skin growth, 2-14 growths | 279 | $59,042 | $7 |
| Short return visit (20+ min) | 309 | $52,464 | $78 |
| Destruction of precancer skin growth, 1 growth | 286 | $40,787 | $59 |
| New patient visit (30+ min) | 201 | $16,704 | $83 |
| Destruction of skin growth, 1-14 growths | 65 | $11,936 | $107 |
See all 12 services
| Destruction of precancer skin growth, 2-14 growths | 279 | $59,042 | $7 |
| Short return visit (20+ min) | 309 | $52,464 | $78 |
| Destruction of precancer skin growth, 1 growth | 286 | $40,787 | $59 |
| New patient visit (30+ min) | 201 | $16,704 | $83 |
| Destruction of skin growth, 1-14 growths | 65 | $11,936 | $107 |
| Return visit (30+ min) | 43 | $11,100 | $118 |
| Destruction of skin growth, 15 or more growths | 28 | $8,255 | $131 |
| Biopsy of related skin growth, first growth | 63 | $6,431 | $95 |
| Injection into skin growth, 1-7 growths | 25 | $1,681 | $36 |
| New patient visit (45+ min) | 11 | $1,099 | $100 |
| Injection of drug or substance under skin or into muscle | 19 | $724 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 32 | $94 | None |
Procedures Medicare counted
| Removal of skin lesions | 1191 | More than 95% of doctors who do this |
| Skin biopsy | 16 | More than 62% of doctors who do this |
Who their Medicare patients are
440 Original Medicare patients in 2024. Average age 73 · Under 65 14% · 85 and older 13% · Women 53% · Also on Medicaid 60% · Health risk score 1.33. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 70% · Diabetes 34% · Chronic kidney disease 23% · Depression 19% · Coronary heart disease 16% · COPD 14% · Atrial fibrillation 13% · Cancer 12% · Heart failure 11% · Dementia 7% · Stroke 7%.
The office billed $468,311, Medicare allowed $292,845 and paid $213,790; for 10,768 services of 25 kinds; $120 of it was for drugs given in the office and $213,670 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 440 | 10,768 | 73 | 1.33 | $468,311 | $213,790 |
| 2023 | 446 | 9,360 | 72 | 1.17 | $409,477 | $184,793 |
| 2022 | 352 | 8,792 | 73 | 1.09 | $405,623 | $185,008 |
| 2021 | 320 | 8,304 | 72 | 1.25 | $390,770 | $183,987 |
| 2020 | 286 | 7,498 | 73 | 1.23 | $310,750 | $137,872 |
| 2019 | 416 | 12,757 | 73 | 1.32 | $491,508 | $209,514 |
| 2018 | 401 | 10,001 | 73 | 1.19 | $578,732 | $187,598 |
| 2017 | 375 | 10,575 | 72 | 1.28 | $586,473 | $172,991 |
| 2016 | 378 | 7,578 | 72 | 1.21 | $493,235 | $135,289 |
| 2015 | 336 | 5,503 | 73 | 1.43 | $356,558 | $117,281 |
| 2014 | 309 | 4,893 | 74 | 1.24 | $310,500 | $126,222 |
| 2013 | 241 | 3,431 | 74 | 1.16 | $221,639 | $80,024 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Destruction of precancer skin growth, 2-14 growths | 262 | $51,001 | $7 |
| Short return visit (20+ min) | 323 | $50,530 | $76 |
| Destruction of precancer skin growth, 1 growth | 277 | $35,839 | $58 |
| New patient visit (30+ min) | 233 | $19,172 | $82 |
| Destruction of skin growth, 1-14 growths | 57 | $8,878 | $108 |
| Destruction of skin growth, 15 or more growths | 30 | $6,873 | $125 |
| Biopsy of related skin growth, first growth | 56 | $6,074 | $98 |
| Return visit (30+ min) | 14 | $1,794 | $120 |
| Injection into skin growth, 1-7 growths | 17 | $1,166 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $69 | None |
2022: 9 services
| Short return visit (20+ min) | 279 | $57,296 | $78 |
| Destruction of precancer skin growth, 2-14 growths | 202 | $46,311 | $7 |
| Destruction of precancer skin growth, 1 growth | 206 | $32,166 | $58 |
| New patient visit (30+ min) | 170 | $13,975 | $82 |
| Destruction of skin growth, 15 or more growths | 49 | $12,888 | $129 |
| Destruction of skin growth, 1-14 growths | 65 | $10,427 | $103 |
| Biopsy of related skin growth, first growth | 52 | $5,934 | $94 |
| Injection into skin growth, 1-7 growths | 12 | $763 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $103 | None |
2021: 8 services
| Short return visit (20+ min) | 261 | $65,391 | $79 |
| Destruction of precancer skin growth, 2-14 growths | 163 | $42,974 | $7 |
| Destruction of precancer skin growth, 1 growth | 170 | $31,479 | $57 |
| Destruction of skin growth, 1-14 growths | 53 | $13,640 | $114 |
| New patient visit (30+ min) | 130 | $10,751 | $83 |
| Biopsy of related skin growth, first growth | 47 | $8,669 | $99 |
| Destruction of skin growth, 15 or more growths | 26 | $6,329 | $132 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $64 | None |
2020: 8 services
| Short return visit (20+ min) | 240 | $45,724 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 164 | $35,169 | $6 |
| Destruction of precancer skin growth, 1 growth | 173 | $28,233 | $55 |
| Destruction of skin growth, 1-14 growths | 35 | $9,226 | $109 |
| New patient visit (30+ min) | 103 | $7,540 | $73 |
| Biopsy of related skin growth, first growth | 57 | $6,521 | $95 |
| Destruction of skin growth, 15 or more growths | 12 | $2,680 | $122 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $137 | None |
2019: 9 services
| Short return visit (20+ min) | 340 | $68,848 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 247 | $53,784 | $5 |
| Destruction of precancer skin growth, 1 growth | 257 | $44,710 | $53 |
| New patient visit (30+ min) | 189 | $14,678 | $78 |
| Biopsy of related skin growth, first growth | 91 | $11,490 | $93 |
| Destruction of skin growth, 1-14 growths | 24 | $6,469 | $106 |
| Injection into skin growth, 1-7 growths | 16 | $1,880 | $35 |
| Biopsy of related skin growth, each additional growth | 13 | $1,157 | $53 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $180 | None |
2018: 10 services
| Short return visit (20+ min) | 313 | $64,209 | $65 |
| Destruction of precancer skin growth, 2-14 growths | 216 | $39,404 | $5 |
| Destruction of precancer skin growth, 1 growth | 220 | $37,092 | $56 |
| New patient visit (30+ min) | 197 | $16,272 | $83 |
| Biopsy of single growth of skin and/or tissue | 104 | $15,253 | $103 |
| Destruction of skin growth, 1-14 growths | 14 | $3,114 | $115 |
| Biopsy of each additional growth of skin and/or tissue | 31 | $1,205 | $32 |
| Injection into skin growth, 1-7 growths | 14 | $966 | $42 |
| Injection of drug or substance under skin or into muscle | 11 | $338 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $124 | None |
2017: 10 services
| Short return visit (20+ min) | 292 | $52,689 | $60 |
| Destruction of precancer skin growth, 2-14 growths | 219 | $43,343 | $5 |
| Destruction of precancer skin growth, 1 growth | 225 | $36,155 | $53 |
| New patient visit (30+ min) | 175 | $13,525 | $77 |
| Biopsy of single growth of skin and/or tissue | 67 | $8,089 | $92 |
| Destruction of skin growth, 1-14 growths | 19 | $5,840 | $101 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 11 | $1,480 | $62 |
| Biopsy of each additional growth of skin and/or tissue | 14 | $626 | $28 |
| Injection of drug or substance under skin or into muscle | 14 | $534 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $157 | None |
2016: 9 services
| Short return visit (20+ min) | 258 | $41,827 | $58 |
| Destruction of precancer skin growth, 1 growth | 173 | $28,716 | $52 |
| Destruction of precancer skin growth, 2-14 growths | 153 | $27,358 | $5 |
| New patient visit (30+ min) | 173 | $11,810 | $68 |
| Biopsy of single growth of skin and/or tissue | 53 | $5,700 | $84 |
| Destruction of skin growth, 1-14 growths | 18 | $5,376 | $96 |
| Injection into skin growth, 1-7 growths | 18 | $1,854 | $39 |
| Short return visit | 22 | $748 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $159 | None |
2015: 12 services
| Short return visit (20+ min) | 179 | $33,030 | $60 |
| Destruction of precancer skin growth, 1 growth | 110 | $20,153 | $54 |
| Destruction of precancer skin growth, 2-14 growths | 96 | $18,150 | $5 |
| New patient visit (30+ min) | 127 | $10,064 | $79 |
| Biopsy of single growth of skin and/or tissue | 69 | $7,537 | $90 |
| Destruction of skin growth, 1-14 growths | 15 | $6,741 | $96 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 17 | $2,548 | $57 |
| Injection into skin growth, 1-7 growths | 21 | $2,493 | $46 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 14 | $1,907 | $136 |
| Short return visit | 49 | $1,901 | $32 |
| Injection of drug or substance under skin or into muscle | 13 | $447 | $24 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 33 | $229 | None |
2014: 12 services
| Destruction of precancer skin growth, 2-14 growths | 103 | $30,580 | $9 |
| Short return visit (20+ min) | 177 | $27,359 | $59 |
| Destruction of precancer skin growth, 1 growth | 110 | $20,098 | $63 |
| Biopsy of single growth of skin and/or tissue | 75 | $9,132 | $90 |
| New patient visit (30+ min) | 95 | $7,446 | $78 |
| Short return visit | 58 | $2,944 | $34 |
| Destruction of skin growth, 1-14 growths | 16 | $2,858 | $92 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 18 | $2,769 | $60 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 17 | $2,458 | $145 |
| Injection into skin growth, 1-7 growths | 14 | $1,049 | $44 |
| Injection of drug or substance under skin or into muscle | 12 | $405 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $144 | None |
2013: 9 services
| Destruction of precancer skin growth, 1 growth | 85 | $15,819 | $68 |
| Destruction of precancer skin growth, 2-14 growths | 83 | $14,400 | $6 |
| Short return visit (20+ min) | 111 | $12,906 | $57 |
| Destruction of skin growth, 15 or more growths | 20 | $10,322 | $120 |
| New patient visit (30+ min) | 74 | $5,993 | $81 |
| Biopsy of single growth of skin and/or tissue | 43 | $4,799 | $92 |
| Short return visit | 76 | $4,563 | $36 |
| Destruction of skin growth, 1-14 growths | 27 | $4,249 | $101 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $42 | None |
Medicaid work
$73,676 in 2024
Medicaid paid $73,676 for 2,022 billed services this clinician did in 2024, up to 93 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 744 | $35,973 |
| Short return visit (20+ min) | 596 | $25,131 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 87 | $4,678 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 297 | $4,356 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 284 | $3,497 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $41 |
| 2024 | 2,022 | 6 | 93 | $73,676 |
| 2023 | 1,984 | 5 | 87 | $85,570 |
| 2022 | 2,050 | 7 | 63 | $80,991 |
| 2021 | 1,996 | 8 | 68 | $91,033 |
| 2020 | 1,337 | 7 | 64 | $86,146 |
| 2019 | 2,177 | 6 | 97 | $143,005 |
| 2018 | 2,722 | 6 | 90 | $111,302 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 810 | $39,596 |
| Short return visit (20+ min) | 572 | $27,829 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 333 | $8,794 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 245 | $7,554 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 24 | $1,798 |
2022
| New patient visit (30+ min) | 573 | $33,736 |
| Short return visit (20+ min) | 511 | $29,784 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 218 | $10,086 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 151 | $7,385 |
| TOBACCO NON-USER | 201 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 203 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 193 | $0 |
2021
| Short return visit (20+ min) | 694 | $42,729 |
| New patient visit (30+ min) | 566 | $31,879 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 140 | $8,135 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 98 | $5,109 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 43 | $3,180 |
| TOBACCO NON-USER | 144 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 164 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 147 | $0 |
2020
| New patient visit (30+ min) | 429 | $41,889 |
| Short return visit (20+ min) | 639 | $38,050 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 58 | $4,239 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 40 | $1,969 |
| TOBACCO NON-USER | 58 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 57 | $0 |
| Patient screened for tobacco use and identified as a tobacco non-user | 56 | $0 |
2019
| New patient visit (30+ min) | 630 | $56,868 |
| Short return visit (20+ min) | 891 | $47,057 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 300 | $20,306 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 263 | $16,278 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 51 | $2,279 |
| Short return visit | 42 | $218 |
2018
| New patient visit (30+ min) | 793 | $39,441 |
| Short return visit (20+ min) | 1,015 | $38,421 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 422 | $16,254 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 466 | $15,414 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 14 | $1,068 |
| Service | 12 | $704 |
Drugs they prescribed that Part D paid
$204,440
Pharmacies billed $204,440 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,292 generic and fewer than 11 brand-name prescriptions · $204,440 in drug cost · 25 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Adbry | 40 | $164,119 | $4,103 |
| Ketoconazole | 280 | $5,032 | $18 |
| Fluocinolone Acetonide | 51 | $4,561 | $89 |
| Doxepin | 24 | $4,483 | $187 |
| Hydrocortisone | 141 | $2,342 | $17 |
See all 23 drugs
| Adbry | 40 | $164,119 | $4,103 |
| Ketoconazole | 280 | $5,032 | $18 |
| Fluocinolone Acetonide | 51 | $4,561 | $89 |
| Doxepin | 24 | $4,483 | $187 |
| Hydrocortisone | 141 | $2,342 | $17 |
| Metronidazole | 17 | $1,988 | $117 |
| Triamcinolone Acetonide | 127 | $1,930 | $15 |
| Clindamycin Phosphate | 85 | $1,860 | $22 |
| Permethrin | 26 | $1,474 | $57 |
| Montelukast | 204 | $1,472 | $7 |
| Gentamicin Sulfate | 18 | $778 | $43 |
| Econazole Nitrate | 18 | $697 | $39 |
| Fluocinolone Acetonide | 11 | $685 | $62 |
| Fluocinonide | 28 | $681 | $24 |
| Tretinoin | 18 | $574 | $32 |
| Mupirocin | 54 | $426 | $8 |
| Methotrexate | 29 | $384 | $13 |
| Amoxicillin-Clavulanate Potass | 20 | $139 | $7 |
| Prednisone | 23 | $138 | $6 |
| Acyclovir | 16 | $114 | $7 |
| Fluconazole | 13 | $76 | $6 |
| Amitriptyline | 12 | $75 | $6 |
| Methylprednisolone | 11 | $49 | $4 |
Year by year
| 2024 | 1,353 | 275 | None | None | $204,440 |
| 2023 | 984 | 229 | None | 2% | $44,829 |
| 2022 | 894 | 204 | None | None | $29,063 |
| 2021 | 983 | 223 | None | None | $51,891 |
| 2020 | 951 | 175 | 2% (14) | 3% | $92,227 |
| 2019 | 1,109 | 232 | 2% (25) | 3% | $47,663 |
| 2018 | 868 | 203 | 1% (11) | 2% | $45,423 |
| 2017 | 768 | 196 | None | 3% | $51,015 |
| 2016 | 694 | 166 | None | 7% | $42,160 |
| 2015 | 692 | 155 | None | None | $44,918 |
| 2014 | 583 | 156 | None | None | $63,653 |
| 2013 | 533 | 121 | None | None | $37,343 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Ketoconazole | 193 | $6,035 | $31 |
| Fluocinolone Acetonide | 35 | $4,209 | $120 |
| Hydrocortisone | 141 | $3,714 | $26 |
| Gentamicin Sulfate | 61 | $2,927 | $48 |
| Triamcinolone Acetonide | 110 | $2,714 | $25 |
| Permethrin | 23 | $2,080 | $90 |
| Montelukast | 147 | $1,968 | $13 |
| Clindamycin Phosphate | 44 | $1,386 | $32 |
| Fluocinonide | 18 | $1,321 | $73 |
| Tretinoin | 13 | $747 | $57 |
| Methotrexate | 22 | $384 | $17 |
| Econazole Nitrate | 12 | $322 | $27 |
| Fluconazole | 15 | $191 | $13 |
| Prednisone | 22 | $185 | $8 |
2022: 11 drugs
| Gentamicin Sulfate | 72 | $5,315 | $74 |
| Ketoconazole | 155 | $4,502 | $29 |
| Triamcinolone Acetonide | 133 | $2,803 | $21 |
| Fluocinolone Acetonide | 22 | $2,782 | $126 |
| Hydrocortisone | 112 | $2,039 | $18 |
| Montelukast | 139 | $1,640 | $12 |
| Clindamycin Phosphate | 39 | $1,469 | $38 |
| Fluconazole | 38 | $328 | $9 |
| Prednisone | 40 | $284 | $7 |
| Methotrexate | 17 | $128 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $101 | $9 |
2021: 16 drugs
| Acitretin | 16 | $19,680 | $1,230 |
| Gentamicin Sulfate | 70 | $4,348 | $62 |
| Ketoconazole | 171 | $4,166 | $24 |
| Triamcinolone Acetonide | 144 | $2,941 | $20 |
| Montelukast | 144 | $1,610 | $11 |
| Hydrocortisone | 106 | $1,600 | $15 |
| Adapalene | 11 | $1,130 | $103 |
| Mycophenolate Mofetil | 13 | $1,045 | $80 |
| Clindamycin Phosphate | 27 | $991 | $37 |
| Ivermectin | 32 | $990 | $31 |
| Fluocinolone Acetonide | 14 | $685 | $49 |
| Fluconazole | 59 | $511 | $9 |
| Doxycycline Monohydrate | 11 | $350 | $32 |
| Amoxicillin-Clavulanate Potass | 22 | $196 | $9 |
| Prednisone | 12 | $153 | $13 |
| Methotrexate | 12 | $65 | $5 |
2020: 18 drugs
| Gentamicin Sulfate | 42 | $4,223 | $101 |
| Ketoconazole | 130 | $4,133 | $32 |
| Triamcinolone Acetonide | 94 | $2,180 | $23 |
| Hydrocortisone | 88 | $1,646 | $19 |
| Fluorouracil | 13 | $1,564 | $120 |
| Fluconazole | 80 | $1,505 | $19 |
| Montelukast | 172 | $1,500 | $9 |
| Ivermectin | 34 | $1,132 | $33 |
| Fluocinolone Acetonide | 11 | $1,014 | $92 |
| Clindamycin Phosphate | 21 | $596 | $28 |
| Amoxicillin-Clavulanate Potass | 26 | $342 | $13 |
| Methotrexate | 15 | $332 | $22 |
| Econazole Nitrate | 11 | $289 | $26 |
| Doxepin | 13 | $285 | $22 |
| Hydrocodone-Acetaminophen | 11 | $259 | $24 |
| Methylprednisolone | 11 | $117 | $11 |
| Mupirocin | 11 | $110 | $10 |
| Hydroxyzine | 15 | $95 | $6 |
2019: 21 drugs
| Acitretin | 15 | $8,038 | $536 |
| Ketoconazole | 150 | $4,920 | $33 |
| Fluocinolone Acetonide | 32 | $4,125 | $129 |
| Hydrocortisone | 128 | $2,783 | $22 |
| Clindamycin Phosphate | 40 | $2,272 | $57 |
| Triamcinolone Acetonide | 102 | $2,075 | $20 |
| Gentamicin Sulfate | 23 | $1,993 | $87 |
| Montelukast | 157 | $1,900 | $12 |
| Methotrexate | 36 | $1,514 | $42 |
| Ivermectin | 37 | $1,140 | $31 |
| Fluconazole | 71 | $862 | $12 |
| Fluocinonide | 14 | $746 | $53 |
| Doxepin | 21 | $535 | $25 |
| Amoxicillin-Clavulanate Potass | 33 | $473 | $14 |
| Mupirocin | 29 | $458 | $16 |
| Erythromycin | 13 | $319 | $25 |
| Acetaminophen-Codeine | 21 | $218 | $10 |
| Methylprednisolone | 14 | $182 | $13 |
| Clindamycin | 17 | $154 | $9 |
| Prednisone | 19 | $139 | $7 |
| Hydroxyzine | 14 | $104 | $7 |
2018: 16 drugs
| Gentamicin Sulfate | 56 | $6,959 | $124 |
| Ketoconazole | 122 | $4,412 | $36 |
| Fluocinolone Acetonide | 18 | $2,390 | $133 |
| Clindamycin Phosphate | 45 | $2,150 | $48 |
| Hydrocortisone | 99 | $2,021 | $20 |
| Triamcinolone Acetonide | 92 | $1,970 | $21 |
| Fluocinonide | 16 | $1,630 | $102 |
| Montelukast | 160 | $1,481 | $9 |
| Doxepin | 16 | $480 | $30 |
| Fluconazole | 30 | $462 | $15 |
| Doxycycline Monohydrate | 16 | $445 | $28 |
| Methotrexate | 16 | $363 | $23 |
| Mupirocin | 19 | $254 | $13 |
| Methylprednisolone | 15 | $152 | $10 |
| Amoxicillin-Clavulanate Potass | 17 | $143 | $8 |
| Clindamycin | 11 | $44 | $4 |
2017: 12 drugs
| Acitretin | 11 | $6,703 | $609 |
| Fluocinolone Acetonide | 32 | $5,713 | $179 |
| Clindamycin Phosphate | 81 | $4,439 | $55 |
| Gentamicin Sulfate | 46 | $4,404 | $96 |
| Ketoconazole | 105 | $3,928 | $37 |
| Triamcinolone Acetonide | 96 | $2,060 | $21 |
| Fluocinonide | 23 | $1,612 | $70 |
| Hydrocortisone | 53 | $1,067 | $20 |
| Econazole Nitrate | 12 | $970 | $81 |
| Montelukast | 102 | $841 | $8 |
| Fluconazole | 30 | $342 | $11 |
| Amoxicillin-Clavulanate Potass | 18 | $171 | $10 |
2016: 13 drugs
| Econazole Nitrate | 39 | $6,626 | $170 |
| Clindamycin Phosphate | 80 | $4,971 | $62 |
| Fluocinolone Acetonide | 31 | $4,477 | $144 |
| Gentamicin Sulfate | 50 | $3,738 | $75 |
| Ketoconazole | 87 | $3,593 | $41 |
| Fluocinonide | 18 | $1,751 | $97 |
| Triamcinolone Acetonide | 73 | $1,515 | $21 |
| Hydrocortisone | 80 | $1,143 | $14 |
| Methotrexate | 18 | $838 | $47 |
| Fluconazole | 27 | $599 | $22 |
| Montelukast | 62 | $543 | $9 |
| Mometasone Furoate | 15 | $466 | $31 |
| Amoxicillin-Clavulanate Potass | 15 | $170 | $11 |
2015: 14 drugs
| Econazole Nitrate | 90 | $11,096 | $123 |
| Fluocinolone Acetonide | 22 | $3,334 | $152 |
| Clindamycin Phosphate | 48 | $3,057 | $64 |
| Gentamicin Sulfate | 57 | $3,000 | $53 |
| Desonide | 20 | $1,841 | $92 |
| Ketoconazole | 54 | $1,603 | $30 |
| Triamcinolone Acetonide | 72 | $1,488 | $21 |
| Mometasone Furoate | 38 | $917 | $24 |
| Hydrocortisone | 62 | $876 | $14 |
| Fluocinonide | 11 | $746 | $68 |
| Fluconazole | 36 | $499 | $14 |
| Montelukast | 37 | $417 | $11 |
| Amoxicillin-Clavulanate Potass | 16 | $197 | $12 |
| Silver Sulfadiazine | 12 | $137 | $11 |
2014: 12 drugs
| Desonide | 51 | $5,812 | $114 |
| Econazole Nitrate | 88 | $3,147 | $36 |
| Clindamycin Phosphate | 35 | $2,433 | $70 |
| Gentamicin Sulfate | 41 | $2,080 | $51 |
| Valacyclovir | 15 | $1,531 | $102 |
| Doxycycline Monohydrate | 12 | $1,024 | $85 |
| Mometasone Furoate | 35 | $965 | $28 |
| Triamcinolone Acetonide | 27 | $913 | $34 |
| Hydrocortisone | 28 | $870 | $31 |
| Ketoconazole | 34 | $715 | $21 |
| Montelukast | 26 | $508 | $20 |
| Fluconazole | 17 | $217 | $13 |
2013: 12 drugs
| Clindamycin Phosphate | 38 | $1,972 | $52 |
| Fluocinolone Acetonide | 14 | $1,916 | $137 |
| Desonide | 33 | $1,763 | $53 |
| Montelukast | 39 | $1,743 | $45 |
| Econazole Nitrate | 75 | $1,388 | $19 |
| Gentamicin Sulfate | 41 | $1,160 | $28 |
| Mometasone Furoate | 32 | $1,088 | $34 |
| Triamcinolone Acetonide | 32 | $871 | $27 |
| Hydrocortisone | 35 | $682 | $19 |
| Lidocaine | 13 | $651 | $50 |
| Ketoconazole | 17 | $251 | $15 |
| Doxepin | 11 | $144 | $13 |
Money from drug and device companies
$1,282 in 2025
| 2025 | 4 | 64 | None | $1,282 |
| 2024 | 5 | 56 | None | $958 |
| 2023 | 5 | 25 | None | $485 |
| 2022 | 6 | 21 | None | $404 |
| 2021 | 6 | 14 | None | $315 |
| 2020 | 5 | 15 | None | $351 |
| 2019 | 6 | 26 | None | $471 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| LEO Pharma | Adbry | $1,139 | 58 payments
|
| Pfizer | Cibinqo | $63 | 3 payments
|
| Organon | Vtama | $48 | 2 payments
|
| Abbvie | Skyrizi | $33 | 1 payment
|
See all 64 published payments
| LEO Pharma | Meals · 2025-12-23 | Adbry | $24 |
| LEO Pharma | Meals · 2025-12-18 | Adbry | $16 |
| LEO Pharma | Meals · 2025-12-18 | Adbry | $16 |
| LEO Pharma | Meals · 2025-12-11 | Adbry | $15 |
| LEO Pharma | Meals · 2025-12-11 | Adbry | $15 |
| Pfizer | Meals · 2025-12-10 | Cibinqo | $23 |
| LEO Pharma | Meals · 2025-12-10 | Adbry | $19 |
| LEO Pharma | Meals · 2025-12-10 | Adbry | $19 |
| LEO Pharma | Meals · 2025-12-04 | Adbry | $19 |
| LEO Pharma | Meals · 2025-12-04 | Adbry | $19 |
| LEO Pharma | Meals · 2025-11-20 | Adbry | $20 |
| Organon | Meals · 2025-11-18 | Vtama | $25 |
| LEO Pharma | Meals · 2025-11-13 | Adbry | $23 |
| LEO Pharma | Meals · 2025-11-06 | Adbry | $24 |
| LEO Pharma | Meals · 2025-10-30 | Adbry | $24 |
| LEO Pharma | Meals · 2025-10-23 | Adbry | $25 |
| LEO Pharma | Meals · 2025-10-15 | Adbry | $25 |
| LEO Pharma | Meals · 2025-10-09 | Adbry | $16 |
| LEO Pharma | Meals · 2025-10-02 | Adbry | $22 |
| LEO Pharma | Meals · 2025-09-25 | Adbry | $28 |
| LEO Pharma | Meals · 2025-09-18 | Adbry | $22 |
| LEO Pharma | Meals · 2025-09-11 | Adbry | $28 |
| LEO Pharma | Meals · 2025-09-04 | Adbry | $27 |
| Pfizer | Meals · 2025-09-03 | Cibinqo | $21 |
| LEO Pharma | Meals · 2025-08-28 | Adbry | $27 |
| LEO Pharma | Meals · 2025-08-21 | Adbry | $28 |
| LEO Pharma | Meals · 2025-08-14 | Adbry | $22 |
| LEO Pharma | Meals · 2025-08-06 | Adbry | $13 |
| LEO Pharma | Meals · 2025-07-31 | Adbry | $13 |
| LEO Pharma | Meals · 2025-07-17 | Adbry | $26 |
| Pfizer | Meals · 2025-07-01 | Cibinqo | $19 |
| LEO Pharma | Meals · 2025-06-25 | Adbry | $24 |
| LEO Pharma | Meals · 2025-06-19 | Adbry | $29 |
| LEO Pharma | Meals · 2025-06-12 | Adbry | $16 |
| LEO Pharma | Meals · 2025-06-07 | Adbry | $19 |
| LEO Pharma | Meals · 2025-05-28 | Adbry | $23 |
| LEO Pharma | Meals · 2025-05-21 | Adbry | $23 |
| LEO Pharma | Meals · 2025-05-16 | Adbry | $21 |
| LEO Pharma | Meals · 2025-05-14 | Adbry | $14 |
| LEO Pharma | Meals · 2025-05-09 | Adbry | $22 |
| LEO Pharma | Meals · 2025-05-07 | Adbry | $14 |
| LEO Pharma | Meals · 2025-04-30 | Adbry | $24 |
| LEO Pharma | Meals · 2025-04-24 | Adbry | $28 |
| LEO Pharma | Meals · 2025-04-17 | Adbry | $14 |
| LEO Pharma | Meals · 2025-04-03 | Adbry | $14 |
| LEO Pharma | Meals · 2025-03-31 | Adbry | $18 |
| LEO Pharma | Meals · 2025-03-27 | Adbry | $21 |
| LEO Pharma | Meals · 2025-03-21 | Adbry | $24 |
| LEO Pharma | Meals · 2025-03-20 | Adbry | $19 |
| LEO Pharma | Meals · 2025-03-13 | Adbry | $14 |
| Organon | Meals · 2025-03-05 | Vtama | $22 |
| LEO Pharma | Meals · 2025-03-05 | Adbry | $13 |
| LEO Pharma | Meals · 2025-02-28 | Adbry | $21 |
| LEO Pharma | Meals · 2025-02-27 | Adbry | $13 |
| LEO Pharma | Meals · 2025-02-20 | Adbry | $18 |
| LEO Pharma | Meals · 2025-02-13 | Adbry | $13 |
| LEO Pharma | Meals · 2025-02-06 | Adbry | $18 |
| LEO Pharma | Meals · 2025-01-31 | Adbry | $13 |
| LEO Pharma | Meals · 2025-01-30 | Adbry | $13 |
| LEO Pharma | Meals · 2025-01-23 | Adbry | $13 |
| LEO Pharma | Meals · 2025-01-17 | Adbry | $13 |
| LEO Pharma | Meals · 2025-01-16 | Adbry | $13 |
| LEO Pharma | Meals · 2025-01-09 | Adbry | $18 |
| Abbvie | Meals · 2025-01-02 | Skyrizi | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $958
| LEO Pharma | Adbry | $608 | 44 payments
|
| Abbvie | Skyrizi | $149 | 7 payments
|
| Janssen Biotech | Tremfya | $125 | 2 payments
|
| Dermavant Sciences | Vtama | $53 | 2 payments
|
| Pfizer | Cibinqo | $24 | 1 payment
|
2023: $485
| Pfizer | Eucrisa | $271 | 16 payments
|
| AbbVie | Skyrizi | $135 | 6 payments
|
| Lilly USA | Taltz | $29 | 1 payment
|
| Incyte | Opzelura | $28 | 1 payment
|
| Janssen Biotech | Tremfya | $23 | 1 payment
|
2022: $404
| Abbvie | Skyrizi | $132 | 9 payments
|
| Janssen Biotech | Remicade | $92 | 5 payments
|
| Sun Pharmaceutical Industries | Winlevi | $69 | 2 payments
|
| Pfizer | Cibinqo | $49 | 2 payments
|
| Lilly USA | Taltz | $47 | 2 payments
|
| Genzyme | Dupixent | $16 | 1 payment
|
2021: $315
| Lilly USA | Taltz | $95 | 4 payments
|
| AbbVie | Skyrizi | $79 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $75 | 3 payments
|
| Janssen Biotech | Remicade | $39 | 2 payments
|
| Genzyme | Dupixent | $14 | 1 payment
|
| Pfizer | Eucrisa | $14 | 1 payment
|
2020: $351
| AbbVie | Skyrizi | $195 | 9 payments
|
| Amgen | Enbrel | $77 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $35 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $32 | 1 payment
|
| Pfizer | Eucrisa | $12 | 1 payment
|
2019: $471
| Amgen | Enbrel | $242 | 17 payments
|
| AbbVie | Humira | $83 | 4 payments
|
| Janssen Scientific Affairs | Tremfya | $81 | 1 payment
|
| LEO Pharma | Enstilar | $28 | 1 payment
|
| Pfizer | Eucrisa | $24 | 2 payments
|
| STRATA Skin Sciences | Xtrac | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1306941620
- Licence
- CA G56359California G56359: Current · expires 2027-06-30
- Trained
- University of California, Davis School of Medicine, 1984
- Group
- Csi Medical Group
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207ND0900X (207ND0900X); Federal specialty code 207N00000X (207N00000X); Federal specialty code 207ND0101X (207ND0101X); Federal specialty code 207NI0002X (207NI0002X); Federal specialty code 207NP0225X (207NP0225X); Federal specialty code 207NS0135X (207NS0135X)
- Mailing address
- 501 S Shore Ctr W, 103a, Alameda, CA, 94501
- NPI first listed
- 2006-09-13
- NPI last updated
- 2013-01-31
This is when the NPI record was last certified, not a medical board exam.